Dandekar Atul's Form 4 filing
Maze Therapeutics, Inc. (MAZE) · filed Apr 1, 2026
- Accession no.
- 0002050167-26-000006
- Filed
- Apr 1, 2026
- Trade date
- Mar 30, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $220.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dandekar AtulCIK 0002050167 | Officer (CSBO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Common Stock | MOption exerciseAcquired | +7,500 | $10.42 | +$78,150 | 18,003 | Direct | |
| Mar 30, 2026 | Common Stock | SSaleDisposed | −6,710 | $29.26 | −$196,334.6 | 11,293 | Direct | |
| Mar 30, 2026 | Common Stock | SSaleDisposed | −790 | $30.02 | −$23,715.8 | 10,503 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 | Common Stock | MOption exerciseDisposed | −7,500 | $0.00 | $0 | 51,643 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.